PolyPeptide Group AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PolyPeptide Group AG generated cash of $36,485,000, which is more than the previous year. Cash used in financing activities reached the amount of $84,547,000 last year. Net change in cash is therefore $58,178,000.
Cash Flow
| 2018 | 22.94M | -18.59M | -3.33M |
|---|---|---|---|
| 2019 | 55.6M | -12.26M | -35.93M |
| 2020 | 49.48M | -42.56M | -6.73M |
| 2021 | 57.35M | -80.84M | 130.92M |
| 2022 | 5.46M | -78.43M | -26.86M |
| 2023 | 36.48M | -59.51M | 84.54M |
PPGN.SW Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 37.52M | 136.30M | 17.20M | 17.50M | 10.03M | 9.12M |
Operating activities | ||||||
Net income | -51.44M | 7.76M | 47.25M | 31.33M | 25.73M | 23.82M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 30.46M | 24.02M | 18.71M | 16.08M | 15.80M | 14.42M |
Stock-based compensation expense | 892K | 1.15M | 1.20M | 0 | 0 | 0 |
| Deferred income tax benefit | 892K | 1.15M | 1.20M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -29.34M | 18.78M | -12.23M | -21.43M | 8.16M | -10.67M |
Inventories | 15.51M | -33.12M | -17.66M | -22.10M | -1.23M | 2.03M |
Accounts payable | 29.34M | 4.98M | 2.25M | -5.36M | -8.16M | 10.67M |
Cash generated by operating activities | 36.48M | 5.46M | 57.35M | 49.48M | 55.6M | 22.94M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 2.18M | -296K |
Investments In Property Plant And Equipment | -52.89M | -75.09M | -73.96M | -40.62M | -19.70M | -18.29M |
Acquisitions Net | 0 | 0 | 0 | 0 | 4.44M | 0 |
Cash generated by investing activities | -59.51M | -78.43M | -80.84M | -42.56M | -12.26M | -18.59M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 182.14M | 0 | 0 | 0 |
Payments for dividends | 0 | -9.67M | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -13.93M | -5.46M | 0 | -16.6M | 0 |
Repayments of term debt | 89.08M | 0 | -41.37M | -9.08M | -11.32M | -6.86M |
Cash used in financing activities | 84.54M | -26.86M | 130.92M | -6.73M | -35.93M | -3.33M |
Net Change In Cash | 58.17M | -98.77M | 119.09M | -300K | 7.47M | 910K |
Cash at end of period | 95.70M | 37.52M | 136.30M | 17.20M | 17.50M | 10.03M |
| Data source | Data source | Data source | Data source | Data source | Data source |